Knee Replacement Clinical Trials

Clinical trials related to Knee Replacement Procedure

Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity, a Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY

Obesity is associated with increased pain with knee osteoarthritis and increase progression of knee osteoarthritis while weight loss intervention has been shown to reduce pain and requirement of total knee replacement. In this study, the investigators will assess using diet modification with exercise, and metformin, a common, safe, diabetes mellitus medication that has been in use for 70 years to achieve better weight control to reduce knee pain. This helps the investigators to understand whether the combined treatment can reduce joint pain, reduce body weight and improve symptoms and requirement of total knee replacement.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 80
Healthy Volunteers: f
View:

• Men and women age between 40 and 80 years old, with overweight or obesity (body mass index ≥23 kg/m2) according to Hong Kong Centre for Health Protection definition of overweight and obesity.

• Knee pain for 6+ months with Visual Analogue Scale (VAS) \> 40mm/100mm and

• Meet the American College of Rheumatology criteria for knee OA

• OA referred for consideration for joint replacement

Locations
Other Locations
Hong Kong Special Administrative Region
Maclehose Medical Rehabilitation
RECRUITING
Hong Kong
Contact Information
Primary
Lawrence Lau, FRCS, PhD
laucml@hku.hk
+852 92646862
Time Frame
Start Date: 2026-08-30
Estimated Completion Date: 2028-07-17
Participants
Target number of participants: 100
Treatments
Experimental: Intervention group
This group of patients will receive metformin (max: 500mgx4=2000mg daily). Both groups will start with an initial dose of 500mg daily and the dose will be gradually titrated to 2000mg daily in 6 weeks to allow patients adopting to the gastrointestinal symptoms. Both groups shall be put on metformin or placebo for 6months and then both groups will stop their respective medications and continue on diet modification and exercise therapy only.
Placebo_comparator: Placebo
This group of patients will receive placebo. The placebos will be manufactured with Good Manufacturing Practice (GMP) standard such that each placebo pill will look like metformin pill (500mg). Both groups will start with an initial dose of 500mg daily and the dose will be gradually titrated to 2000mg daily in 6 weeks to allow patients adopting to the gastrointestinal symptoms. Both groups shall be put on metformin or placebo for 6months and then both groups will stop their respective medications and continue on diet modification and exercise therapy only.
Sponsors
Leads: The University of Hong Kong

This content was sourced from clinicaltrials.gov